Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?
Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come.
Society Pass currently has its fingers in the Travel, Fashion,...
Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?
We Think Yes..!
With the year just finished ringing in $17.8 million in revenues, versus a market capitalization of just $3 million - we actually...
Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?
After dropping 94% from post IPO high from $19.45, a loss exceeding $3 billion and change, ATAI is in the early stages of recovery (in our opinion)...
The Ketamine Endgame. Silo Pharmaceutical (SILO).
James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd Annual Psychedelic Therapeutics and Drug Development Conference.
Dr....
The Ketamine Cure (NY Times)
The once-taboo drug has been repurposed to treat depression and is even available for delivery. But how safe is it?
By David Dodge NYT | Published Nov....
A Good Bear Market, is a Terrible Thing to Waste. How to Short Real...
"The commercial real estate market is tumbling toward a crash that could be as devastating as the 2008-09 crisis. The party’s over, unfortunately. The...
Ardelyx (ARDX) Resubmits New Drug Application to FDA.
WALTHAM, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize...
Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.
Rick Doblin, Recently Visited one of Psycheceutical's Labs.
Psycheceutical Bioscience, Inc. Is Developing a Topical Application Of Ketamine Targeted to Relieve PTSD Symptoms Within Minutes...
And we Have Another Triple! Ardelyx (ARDX) Touches $5.00, up 333%.
LIVE QUOTE
Ardelyx Enters the Danger Zone* With Tenapanor.
The company produced favorable (albeit very technical) information (data) at the National Kidney Foundation 2023 Spring Clinical...
Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.
If we average out the two most recent price targets this month, we come out with a potential gain of 337% and that ain't...